← SynDRA
ERDAFITINIB
SynDRA canonical compound SYN0038290 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Primary target(s) | FGFR1 | FGFR2 | FGFR3 | FGFR4 |
| Mechanism of action | FGFR inhibitor |
All known targets
- FGFR1
- FGFR2
- FGFR3
- FGFR4
- KDR
Mechanisms of action (all sources)
- FGFR3 INHIBITOR
- Fibroblast growth factor receptor inhibitor
- FGFR1 INHIBITOR
- FGFR4 INHIBITOR
- FGFR2 INHIBITOR
- KDR INHIBITOR
- FGFR inhibitor
Drug classes
- Kinase Inhibitor
- Cytochrome P450 3A4 Inhibitors
- P-Glycoprotein Inhibitors
- Cytochrome P450 3A4 Inducers
- Organic Cation Transporter 2 Inhibitors
- Fibroblast Growth Factor Receptor Inhibitors
ATC classes
- L01E · PROTEIN KINASE INHIBITORS
Cross-references
Synonyms
- balversa
- JNJ-42756493
- G-024
- Balversa
- UNII-890E37NHMV
- 890E37NHMV
- Erdafitinib [USAN:INN]
- Erdafitinib (USAN/INN)
- GTPL9039
- SCHEMBL2583760
- CHEMBL3545376
- MolPort-044-560-398
- JNJ-42756493 (Erdafitinib)
- s8401
- compound 4 [WO2011135376]
- ZINC168520308
- AKOS030526429
- CS-4988
- DB12147
- AC-30222
- 1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-
- HY-18708
- AS-35040
- KB-333716
- D10927
- N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quino
- JNJ 42756493
- JNJ42756493
- N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine
- N1-(3,5-dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine
- Erdafitinib [INN]
- Balversa (TN)
- ERDAFITINIB [MI]
- ERDAFITINIB [JAN]
- ERDAFITINIB [USAN]
- ERDAFITINIB [WHO-DD]
- ERDAFITINIB [ORANGE BOOK]
- Erdafitinib(JNJ-42756493)
Look up ERDAFITINIB in the interactive SynDRA portal →